| | Scope | Document part | Language | Document |
|---|
| AUT Ärztegesetz 08-Mar-2023 § 51 (3) | G | § 51 (3) | DE | AUT Ärztegesetz 08-Mar-2023 |
| DEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019 § 20 | HM | § 20 | DE | DEU AMWHV – Arzneimittel- und Wirkstoffherstellungs-verordnung 09-Aug-2019 |
| DEU BGB - Bürgerliches Gesetzbuch 22-Dec-2023 § 630 | G | § 630 | DE | DEU BGB - Bürgerliches Gesetzbuch 22-Dec-2023 |
| DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 - | G | - | DE | DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 |
| DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 3 3.7 | NIS | Leitlinie 3
3.7 | DE | DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 |
| DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 7 | NIS | Leitlinie 7 | DE | DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 |
| DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Ende | NIS | 2.2.1 - Ende | DE | DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 |
| DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Start | NIS | 2.2.1 - Start | DE | DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 |
| DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 10 Absatz 3 | G | § 10
Absatz 3 | DE | DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 |
| DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 33 Absatz 2 | MD | § 33
Absatz 2 | DE | DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 |
| EU EMA/431265/2016 Annex I – to guidance for the conduct of good clinical practice inspections – investigator site 06-Sep-2017 4. | G | 4. | EN | EU EMA/431265/2016 Annex I – to guidance for the conduct of good clinical practice inspections – investigator site 06-Sep-2017 |
| EU EMA/INS/GCP/143492/2022 - ANNEX I TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE CHMP: INVESTIGATOR SITE 2022 Page 6 | G | Page 6 | EN | EU EMA/INS/GCP/143492/2022 - ANNEX I TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE CHMP: INVESTIGATOR SITE 2022 |
| EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.2 | G | 3.5.2 | EN | EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 |
| EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.3 | G | 3.5.3 | EN | EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 |
| EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011 4 | G | 4 | EN | EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011 |
| EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 4.5 | HM | 4.5 | EN | EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter II Section 1.7 | MD | Annex XV
Chapter II
Section 1.7 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 1. ; 3. | MD | Annex XV
Chapter III
1. ; 3. | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III Paragraph 3 | MD | Annex XV
Chapter III
Paragraph 3 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72 Paragraph 3 – 4-001 | MD | Article 72
Paragraph 3 – 4 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72 Paragraph 3 – 4-002 | MD | Article 72
Paragraph 3 – 4 | EN | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter I Section 1.8 | IVD | Annex XIV
Chapter I
Section 1.8 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 3-001 | IVD | Annex XIV
Chapter II
Section 3 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 3-002 | IVD | Annex XIV
Chapter II
Section 3 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68 Paragraph 3 – 4-001 | IVD | Article 68
Paragraph 3 – 4 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 68 Paragraph 3 – 4-002 | IVD | Article 68
Paragraph 3 – 4 | EN | EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 ANNEX I Section K No. 59-60 | HM | ANNEX I
Section K
No. 59-60 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 56 | HM | Article 56 | EN | EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 |
| FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1 | G | 2.1 | FR | FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 |
| FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 2.1.2 | G | 2.1.2 | FR | FRA DHOS/E1/DAF/DPACI no 2007-322 14-Aug-2007 |
| ICH ICH E6 Guideline R3 (2025) Appendix B 14.3 | G | Appendix B
14.3 | EN | ICH ICH E6 Guideline R3 (2025) |
| ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.4.3-001 | MD | 7.4.3 | EN | ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 |
| ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.4.3-002 | MD | 7.4.3 | EN | ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.57-001 | HM | § 312.57 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.57-002 | HM | § 312.57 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.62 | HM | § 312.62 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.62 (c) | HM | § 312.62
(c) | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.6 | G | § 54.6 | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 Subpart G | MD | Subpart G | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.140 (a) (3) (ii) | MD | § 812.140
(a) (3) (ii) | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.140 (b) (5) | MD | § 812.140
(b) (5) | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 45 CFR Part 160 09-Apr-2025 § 164.526 | G | § 164.526 | EN | USA 45 CFR Part 160 09-Apr-2025 |
| USA 45 CFR Part 46 09-Apr-2025 § 46.115 | G | § 46.115 | EN | USA 45 CFR Part 46 09-Apr-2025 |
| USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 6 | G | 6 | EN | USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 |
| WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report - | G | - | EN | WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report |
| WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 8 | HM | 8 | EN | WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 |